Clinical Trial Update: Liraglutide and Peripheral Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating liraglutide in people with type 2 diabetes mellitus and peripheral arterial disease has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Type 2 Diabetes, Peripheral Arterial Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-03-03